Let's dive in.

MOH said it will provide an update when it is ready, with a decision expected to be made in 2026. Read more at ...

Long-term results from the OLYMPIA open-label extension study show that nemolizumab (Nemluvio) provides durable efficacy and ...

Health experts have warned that eyelash extensions - a popular beauty treatment used to lengthen and thicken natural lashes - ...

Many Nigerians resort to unlicensed medicine vendors for cheap remedies, but this practice is life-threatening. Learn about ...

Eli Lilly’s phase 3 ADorable-1 trial of Ebglyss in paediatric patients with moderate-to-severe atopic dermatitis meets primary and key secondary endpoints: Indianapolis Tuesday, ...

A worker sprays pollen fixatives on juniper trees in Beijing on Sunday. [Photo provided to China Daily] Beijing has rolled ...

Eli Lilly scored $408 million in U.S. sales of eczema treatment Ebglyss in its first full year on the market in 2025. | With ...

Almost everyone carries microscopic mites on their skin. They live inside pores and hair follicles, feeding on skin oils and ...

The odds of being struck by lightning in America in a given year are one in 1.2 million. How does the experience reorient a ...

Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today announced positive, top-line ...